MATREGENIX
Enhancing Dental and Craniomaxillofacial Surgery Outcomes with Cost-Effective and Scalable Animal-Free Amino Acid-Based Membranes for Guided Bone Regeneration
MATREGENIX operates in national institute of dental and craniofacial research based in BOSTON, MA.
Profile
Matregenix develops advanced nanofiber-based biomaterials that mimic native tissue architecture to regenerate damaged soft tissue—engineered synthetic alternatives to costly animal- and human-derived materials.
As a business in national institute of dental and craniofacial research, MATREGENIX is listed here with the public details available about it.
The company is recorded as being based in BOSTON, MA.
Its current recorded stage is SBIR/STTR.
It has disclosed roughly $1.1M in funding.
| Sector | National Institute of Dental and Craniofacial Research |
|---|---|
| Headquarters | BOSTON, MA |
| Country | United States |
| Stage | SBIR/STTR |
| Total funding | $1,119,000 |
Website: matregenix.com
Browse related
Create a free account